Konstantinidis, T.G.; Zisaki, S.; Mitroulis, I.; Konstantinidou, E.; Kontekaki, E.G.; Romanidou, G.; Karvelas, A.; Nanousi, I.; Lazidis, L.; Cassimos, D.;
et al. Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2. J. Clin. Med. 2021, 10, 2842.
https://doi.org/10.3390/jcm10132842
AMA Style
Konstantinidis TG, Zisaki S, Mitroulis I, Konstantinidou E, Kontekaki EG, Romanidou G, Karvelas A, Nanousi I, Lazidis L, Cassimos D,
et al. Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2. Journal of Clinical Medicine. 2021; 10(13):2842.
https://doi.org/10.3390/jcm10132842
Chicago/Turabian Style
Konstantinidis, Theocharis G., Stavroula Zisaki, Ioannis Mitroulis, Eleni Konstantinidou, Eftychia G. Kontekaki, Gioulia Romanidou, Alexandros Karvelas, Ioanna Nanousi, Leonidas Lazidis, Dimitrios Cassimos,
and et al. 2021. "Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2" Journal of Clinical Medicine 10, no. 13: 2842.
https://doi.org/10.3390/jcm10132842
APA Style
Konstantinidis, T. G., Zisaki, S., Mitroulis, I., Konstantinidou, E., Kontekaki, E. G., Romanidou, G., Karvelas, A., Nanousi, I., Lazidis, L., Cassimos, D., Tsigalou, C., Martinis, G., & Panopoulou, M.
(2021). Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2. Journal of Clinical Medicine, 10(13), 2842.
https://doi.org/10.3390/jcm10132842
